Table 2.
Characteristics of patients who were successfully converted to sinus rhythm per group.
| Variable | Successful conversion | Failed conversion | p-value |
|---|---|---|---|
| LAD, mm | |||
| - Amiodarone group | 37.5 ± 7.4 | 42.7 ± 7.1 | 0.001∗ |
| - Propafenone group | 38.1 ± 7.3 | 42.6 ± 6.2 | 0.005∗ |
| LVEF, % | |||
| - Amiodarone group | 54 ± 4 | 53 ± 9 | 0.311 |
| - Propafenone group | 53 ± 8 | 54 ± 6 | 0.318 |
| LVEDD, mm | |||
| - Amiodarone group | 54.2 ± 3.0 | 55.1 ± 5.0 | 0.124 |
| - Propafenone group | 53.8 ± 2.7 | 54 ± 3.2 | 0.633 |
| Troponin I, ng/mL | |||
| - Amiodarone group | 0.44 ± 0.28 | 0.46 ± 0.37 | 0.667 |
| - Propafenone group | 0.45 ± 0.21 | 0.46 ± 0.35 | 0.806 |
| NLR | |||
| - Amiodarone group | 2.7 ± 1.5 | 2.6 ± 1.7 | 0.659 |
| - Propafenone group | 2.6 ± 1.32 | 2.8 ± 1.48 | 0.314 |
| hsCRP level, mg/dL | |||
| - Amiodarone group | 2.9 ± 1.5 | 3.8 ± 1.4 | 0.019∗ |
| - Propafenone group | 2.6 ± 1.4 | 3.4 ± 1.5 | 0.013∗ |
hsCRP; High sensitivity C-reactive protein, LAD; Left atrial diameter, LVEDD; Left ventricular end-diastolic dimension, LVEF; Left ventricular ejection fraction, NLR; Neutrophil to lymphocyte ratio.
Data are presented as mean ± SD.
∗p value was considered significant at a level <0.05.